Bioactive Cancer Surgery Filler
Tech ID
P27-1155
Patent Status
Granted in India
Design Status
--
Technical Description
A novel space filler material for post-cancer surgery. It is composed of 2D or 3D soft materials, like glycans, glycopolymers, and chitosan assemblies. The material supports the selective release of the drug-conjugated chitosan molecules, thereby limiting secondary metastasis and the recurrence of cancer cells after cancer surgery.
Problems Addressed
- Low Existing Treatment Efficacy
- Cancer Recurrence
- Lacks Polymeric Assemblies
- Lack of Effective Space Filler Materials
- Metastasis
- Cancer Cell Proliferation
- Allergic Reactions and Side Effects
TARGET AUDIENCE
- Pharmaceutical Industries
- Medical Device Industries
- Cancer Research
- Research and Development
TECH FEATURES
- Antitumor Biomaterial
- Sustainable Drug Release
- Effective Primary Cancer Treatment
- Glycan & Glycopolymer Integration
- Flexibility & Morphological Variability
- Anti-Cancer Drug Conjugation
- 2D or 3D Polymeric Assemblies
- Limits Secondary Metastasis
- Prevents Cancer Recurrence
- Inhibits Cell Proliferation
P27-1155
Send download link to email.
Available For
Available for exclusive and non exclusive license
Sell off
Cost
—
Stage of Developments
Technology Validated
Contact Person
Mr. Lalit Ambastha
IP Bazzaar Technology Pvt. Ltd.
IP Bazzaar Technology Pvt. Ltd.
12 First Floor, National Park, Lajpat Nagar-IV,
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com
New Delhi-110024, India
Tel: [+91] 11-26360036;
Fax: [+91] 11-26360037;
Mobile: [+91]9811367838;
Email: tech@ipbazzaar.com;
www.ipbazzaar.com